Clinical Trials Sponsored by Eyetech Pharmaceuticals

Total 20366 results

1
2
3
4
5
6
7
8
9
10
...
407
408
›

Eyetech Pharmaceuticals

Completed

Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula

Diabetic Macular Edema
Eyetech Pharmaceuticals

Completed

Phase II/III Study of Anti-VEGF in Neovascular AMD

Macular Degeneration | Choroidal Neovascularization

United States
Eyetech Pharmaceuticals
Pfizer

Terminated

A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)

Macular Degeneration

United States
Eyetech Pharmaceuticals
Pfizer

Completed

Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)

Retinal Vein Occlusion

United States
Eyetech Pharmaceuticals
Pfizer

Terminated

Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

United States
Eyetech Pharmaceuticals
Pfizer

Completed

Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD)

Macular Degeneration
Eyetech Pharmaceuticals
Pfizer

Completed

Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration
Eyetech Pharmaceuticals
Pfizer

Unknown

A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD

Age-Related Macular Degeneration (AMD)

United States
Eyetech Pharmaceuticals
Pfizer

Completed

A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD.

Age-Related Macular Degeneration
Eyetech Pharmaceuticals
Pfizer

Completed

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Macular Degeneration

United States
Hermann Eye Center
Eyetech Pharmaceuticals

Completed

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

Diabetic Retinopathy | Iris Neovascularization

United States
Johns Hopkins University
Eyetech Pharmaceuticals

Terminated

Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics

Cystoid Macular Edema

United States
Johns Hopkins University
Eyetech Pharmaceuticals

Terminated

The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema

Cystoid Macular Edema

United States
Retina Institute of Hawaii
Eyetech Pharmaceuticals

Available

A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema (GUARDIAN)

Diabetic Macular Edema

United States
Palmetto Retina Center, LLC
Pfizer; Eyetech Pharmaceuticals

Completed

Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

United States
AceTech

Recruiting

The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients

Breast Cancer | Radiation Dermatitis

Israel
AceTech

Active, not recruiting

Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis

Radiation Dermatitis

Israel
ERYtech Pharma

No longer available

Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase (EAP)

Acute Lymphoblastic Leukemia

France
ERYtech Pharma

Completed

Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

Pancreatic Adenocarcinoma Metastatic

France
ERYtech Pharma

Terminated

L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL

Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma

United States
ERYtech Pharma

Completed

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC (Trybeca-1)

Pancreatic Adenocarcinoma

United States, United Kingdom, France
ERYtech Pharma

Terminated

Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2)

Triple Negative Breast Cancer

Spain, Belgium, Hungary
ERYtech Pharma

Completed

GRASPA Treatment for Patients With Acute Myeloblastic Leukemia (ENFORCE)

Acute Myeloid Leukemia

France
ERYtech Pharma

Completed

GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia (GRASPIVOTALL)

Acute Lymphoblastic Leukemia, in Relapse

France, Belgium
ERYtech Pharma

Completed

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia
ERYtech Pharma

Completed

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer

Pancreatic Cancer
Epitech Mag Ltd.

Terminated

Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease (OMNS)

Dry Eye Syndromes | Sjogren's Syndrome | ATD

Israel
Epitech Mag Ltd.

Completed

Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye

Dry Eye | Dry Eye Syndromes | Sjogren's Syndrome | Meibomian Gland Dysfunction | Aqueous Tear Deficiency

Israel
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

Ovarian Epithelial Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer

Advanced Head and Neck Cancer

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma (rAd-p53)

Non-small Cell Lung Cancer

China
Georgetown University
ERYtech Pharma

Active, not recruiting

Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma

Metastatic Pancreatic Ductal Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma

United States
University Hospital, Clermont-Ferrand
Society ELITECH

Completed

Descriptive Study of Pathogens Involved in Summer Diarrhea in Children Leading to Pediatric Emergency Room Visits (PE-DIA) (PE-DIA)

Diarrhea, Infantile

France
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma

HCC | Diabetes

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion

Malignant Pleural Effusion

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Neoplasms

China
ERYtech Pharma
Centre Leon Berard

Completed

Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia (GRASPALL)

Acute Lymphoblastic Leukemia

France
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma (HCC)

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

Trans-catheter Chemo-embolization Combined With rAd-p53 Gene Injection in Treatment of Advanced Hepatocellular Carcinoma

Advanced Adult Hepatocellular Carcinoma

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors

Advanced Malignant Thyroid Tumors

China
Shenzhen SiBiono GeneTech Co.,Ltd

Unknown

rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors (rAd-p53)

Advanced Oral and Maxillofacial Malignant Tumors

China
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Epitech Group SpA
Azienda Ospedaliera "Sant'Andrea"

Completed

Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients

Covid19

Italy
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Renal Impairment
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip (FACT OA2)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee (FACT CLBP 1)

Osteoarthritis | Chronic Low Back Pain

United States

1
2
3
4
5
6
7
8
9
10
...
407
408
›

3

Subscribe